TY  - GEN
AU  - Frey,Noelle V
AU  - Shaw,Pamela A
AU  - Hexner,Elizabeth O
AU  - Pequignot,Edward
AU  - Gill,Saar
AU  - Luger,Selina M
AU  - Mangan,James K
AU  - Loren,Alison W
AU  - Perl,Alexander E
AU  - Maude,Shannon L
AU  - Grupp,Stephan A
AU  - Shah,Nirav N
AU  - Gilmore,Joan
AU  - Lacey,Simon F
AU  - Melenhorst,Jos J
AU  - Levine,Bruce L
AU  - June,Carl H
AU  - Porter,David L
TI  - Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia
SN  - 1527-7755
PY  - 2020///0908
KW  - Adult
KW  - Age Factors
KW  - Aged
KW  - Female
KW  - Humans
KW  - Immunotherapy, Adoptive
KW  - adverse effects
KW  - Male
KW  - Middle Aged
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - therapy
KW  - Receptors, Antigen, T-Cell
KW  - therapeutic use
KW  - Survival Rate
KW  - Young Adult
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.19.01892
ER  -